AIM IMMUNOTECH INC. Stock-Based Compensation
AIM IMMUNOTECH INC. (AIM) reported Stock-Based Compensation of $60.00 thousand for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-27.
Financial Statements › Cash Flow › Operating Activities
us-gaap:ShareBasedCompensation · last filed 2026-08-07
- AIM IMMUNOTECH INC. share-based payment arrangement, noncash expense for the quarter ending 2025-12-31 was $0.00, a 100.00% decline year-over-year.
- AIM IMMUNOTECH INC. share-based payment arrangement, noncash expense for the quarter ending 2025-09-30 was $0.00, a 100.00% decline year-over-year.
- AIM IMMUNOTECH INC. share-based payment arrangement, noncash expense for the quarter ending 2025-06-30 was $0.00, a 100.00% decline year-over-year.
- AIM IMMUNOTECH INC. share-based payment arrangement, noncash expense for the quarter ending 2025-03-31 was $60.00K, a 25.00% decline year-over-year.
- AIM IMMUNOTECH INC. share-based payment arrangement, noncash expense for fiscal 2025 was $60.00K, a 91.25% decline from fiscal 2024.
- AIM IMMUNOTECH INC. share-based payment arrangement, noncash expense for fiscal 2024 was $686.00K, a 182.30% increase from fiscal 2023.
- AIM IMMUNOTECH INC. share-based payment arrangement, noncash expense for fiscal 2023 was $243.00K, a 74.53% decline from fiscal 2022.
- AIM IMMUNOTECH INC. share-based payment arrangement, noncash expense for fiscal 2022 was $954.00K, a 39.16% decline from fiscal 2021.
| Period end | Share-based Payment Arrangement, Noncash Expense 3 month | Share-based Payment Arrangement, Noncash Expense 6 month | Share-based Payment Arrangement, Noncash Expense 9 month | Share-based Payment Arrangement, Noncash Expense 12 month | Share-based Payment Arrangement, Noncash Expense 12 month as first filed |
|---|---|---|---|---|---|
| 2025-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-27 | $0.00 derived: sum of 2 quarters · filed 2026-03-27 | $0.00 derived: sum of 3 quarters · filed 2026-08-07 | $60.00K 10-K · filed 2026-03-27 | |
| 2025-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-17 | $0.00 derived: sum of 2 quarters · filed 2026-08-07 | $60.00K 10-Q · filed 2025-11-17 | $256.00K derived: sum of 4 quarters · filed 2026-08-07 | |
| 2025-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-07 | $60.00K 10-Q · filed 2026-08-07 | $256.00K derived: sum of 3 quarters · filed 2026-08-07 | $336.00K derived: sum of 4 quarters · filed 2026-08-07 | |
| 2025-03-31 | $60.00K 10-Q · filed 2026-05-15 | $256.00K derived: sum of 2 quarters · filed 2026-05-15 | $336.00K derived: sum of 3 quarters · filed 2026-05-15 | $416.00K derived: sum of 4 quarters · filed 2026-05-15 | |
| 2024-12-31 | $196.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-27 | $276.00K derived: sum of 2 quarters · filed 2026-03-27 | $356.00K derived: sum of 3 quarters · filed 2026-03-27 | $686.00K 10-K · filed 2026-03-27 | |
| 2024-09-30 | $80.00K 10-Q · filed 2024-11-14 | $160.00K derived: sum of 2 quarters · filed 2024-11-14 | $490.00K 10-Q · filed 2025-11-17 | $301.00K derived: sum of 4 quarters · filed 2025-05-15 | |
| 2024-06-30 | $80.00K 10-Q · filed 2024-08-14 | $160.00K 10-Q · filed 2025-08-14 | $221.00K derived: sum of 3 quarters · filed 2025-05-15 | $271.00K derived: sum of 4 quarters · filed 2025-05-15 | |
| 2024-03-31 | $80.00K 10-Q · filed 2025-05-15 | $141.00K derived: sum of 2 quarters · filed 2025-05-15 | $191.00K derived: sum of 3 quarters · filed 2025-05-15 | $241.00K derived: sum of 4 quarters · filed 2025-05-15 | |
| 2023-12-31 | $61.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-27 | $111.00K derived: sum of 2 quarters · filed 2025-03-27 | $161.00K derived: sum of 3 quarters · filed 2025-03-27 | $243.00K 10-K · filed 2025-03-27 | |
| 2023-09-30 | $50.00K 10-Q · filed 2024-11-14 | $100.00K derived: sum of 2 quarters · filed 2024-11-14 | $182.00K 10-Q · filed 2024-11-14 | $344.00K derived: sum of 4 quarters · filed 2024-11-14 | |
| 2023-06-30 | $50.00K 10-Q · filed 2024-08-14 | $132.00K 10-Q · filed 2024-08-14 | $294.00K derived: sum of 3 quarters · filed 2024-08-14 | $569.00K derived: sum of 4 quarters · filed 2024-08-14 | |
| 2023-03-31 | $82.00K 10-Q · filed 2024-05-15 | $244.00K derived: sum of 2 quarters · filed 2024-05-15 | $519.00K derived: sum of 3 quarters · filed 2024-05-15 | $794.00K derived: sum of 4 quarters · filed 2024-05-15 | |
| 2022-12-31 | $162.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-04-01 | $437.00K derived: sum of 2 quarters · filed 2024-04-01 | $712.00K derived: sum of 3 quarters · filed 2024-04-01 | $954.00K 10-K · filed 2024-04-01 | |
| 2022-09-30 | $275.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-14 | $550.00K derived: sum of 2 quarters · filed 2023-11-14 | $792.00K 10-Q · filed 2023-11-14 | $1.04M derived: sum of 4 quarters · filed 2023-11-14 | |
| 2022-06-30 | $275.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-14 | $517.00K 10-Q · filed 2023-08-14 | $765.00K derived: sum of 3 quarters · filed 2023-08-14 | $1.08M derived: sum of 4 quarters · filed 2023-08-14 | |
| 2022-03-31 | $242.00K 10-Q · filed 2023-05-15 | $490.00K derived: sum of 2 quarters · filed 2023-05-15 | $804.00K derived: sum of 3 quarters · filed 2023-05-15 | $1.28M derived: sum of 4 quarters · filed 2023-05-15 | |
| 2021-12-31 | $248.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-31 | $562.00K derived: sum of 2 quarters · filed 2023-03-31 | $1.04M derived: sum of 3 quarters · filed 2023-03-31 | $1.57M 10-K · filed 2023-03-31 | |
| 2021-09-30 | $314.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-14 | $794.00K derived: sum of 2 quarters · filed 2022-11-14 | $1.32M 10-Q · filed 2022-11-14 | $1.76M derived: sum of 4 quarters · filed 2022-11-14 | |
| 2021-06-30 | $480.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-15 | $1.01M 10-Q · filed 2022-08-15 | $1.45M derived: sum of 3 quarters · filed 2022-08-15 | $1.70M derived: sum of 4 quarters · filed 2022-08-15 | |
| 2021-03-31 | $526.00K 10-Q · filed 2022-05-13 | $966.00K derived: sum of 2 quarters · filed 2022-05-13 | $1.22M derived: sum of 3 quarters · filed 2022-05-13 | $1.37M derived: sum of 4 quarters · filed 2022-05-13 | |
| 2020-12-31 | $440.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-31 | $690.00K derived: sum of 2 quarters · filed 2022-03-31 | $840.00K derived: sum of 3 quarters · filed 2022-03-31 | $1.04M 10-K · filed 2022-03-31 | |
| 2020-09-30 | $250.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-15 | $400.00K derived: sum of 2 quarters · filed 2021-11-15 | $596.00K 10-Q · filed 2021-11-15 | $800.00K derived: sum of 4 quarters · filed 2021-11-15 | |
| 2020-06-30 | $150.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-16 | $346.00K 10-Q · filed 2021-08-16 | $550.00K derived: sum of 3 quarters · filed 2021-08-16 | $773.00K derived: sum of 4 quarters · filed 2021-08-16 | |
| 2020-03-31 | $196.00K 10-Q · filed 2021-05-17 | $400.00K derived: sum of 2 quarters · filed 2021-05-17 | $623.00K derived: sum of 3 quarters · filed 2021-05-17 | $874.00K derived: sum of 4 quarters · filed 2021-05-17 | |
| 2019-12-31 | $204.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-31 | $427.00K derived: sum of 2 quarters · filed 2021-03-31 | $678.00K derived: sum of 3 quarters · filed 2021-03-31 | $853.00K 10-K · filed 2021-03-31 | |
| 2019-09-30 | $223.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-12 | $474.00K derived: sum of 2 quarters · filed 2020-11-12 | $649.00K 10-Q · filed 2020-11-12 | $827.00K derived: sum of 4 quarters · filed 2020-11-12 | |
| 2019-06-30 | $251.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-14 | $426.00K 10-Q · filed 2020-08-14 | $604.00K derived: sum of 3 quarters · filed 2020-08-14 | $743.00K derived: sum of 4 quarters · filed 2020-08-14 | |
| 2019-03-31 | $175.00K 10-Q · filed 2020-05-14 | $353.00K derived: sum of 2 quarters · filed 2020-05-14 | $492.00K derived: sum of 3 quarters · filed 2020-05-14 | $818.00K derived: sum of 4 quarters · filed 2020-05-14 | |
| 2018-12-31 | $178.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-30 | $317.00K derived: sum of 2 quarters · filed 2020-03-30 | $643.00K derived: sum of 3 quarters · filed 2020-03-30 | $929.00K 10-K · filed 2020-03-30 | |
| 2018-09-30 | $139.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-14 | $465.00K derived: sum of 2 quarters · filed 2019-11-14 | $751.00K 10-Q · filed 2019-11-14 | $1.04M derived: sum of 4 quarters · filed 2019-11-14 | |
| 2018-06-30 | $326.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-14 | $612.00K 10-Q · filed 2019-08-14 | $897.00K derived: sum of 3 quarters · filed 2019-08-14 | ||
| 2018-03-31 | $286.00K 10-Q · filed 2019-05-15 | $571.00K derived: sum of 2 quarters · filed 2019-05-15 | |||
| 2017-12-31 | $285.00K derived: 10-K 12 month − 10-Q 9 month · filed 2019-04-01 | $571.00K 10-K · filed 2019-04-01 | $86.00K 10-K · filed 2018-03-30 | ||
| 2017-09-30 | $286.00K 10-Q · filed 2018-11-14 | ||||
| 2016-12-31 | $52.00K 10-K · filed 2018-03-30 | ||||
| 2015-12-31 | $121.00K 10-K · filed 2018-03-30 | ||||
| 2014-12-31 | $223.00K 10-K · filed 2017-03-31 | ||||
| 2013-12-31 | $219.00K 10-K · filed 2016-03-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ) | United States | $0.006B | |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| PharmaCyte Biotech, Inc. (PMCB) | United States | $0.005B | |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| WINDTREE THERAPEUTICS INC /DE/ (WINT) | United States | $0.003B | -0.32 |
| VivoSim Labs, INC. (VIVS) | United States | $0.003B | |
| Calidi Biotherapeutics, Inc. (CLDI) | United States | $0.003B | |
| CURIS INC (CRIS) | United States | $0.002B | -0.05 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |
| Silexion Therapeutics Corp (SLXN) | $0.001B |